CureSearch Directors provide outstanding executive leadership, experience and expertise from the areas of business, finance, medical research, and more. Many directors have experienced childhood cancer in their own families or with close friends, and they understand the challenges facing patients and families today.
Chair of the Board
Jared Brancazio, WMS®
Currently VP, Investments at Brancazio Wealth Management of Raymond James, Mr. Brancazio has spent more than 20 years in high level finance and investment roles and has also served in key volunteer leadership roles at organizations including the Leukemia & Lymphoma Society, Florida Cancer Specialists Foundation and Florida Southwestern State College Foundation. Mr. Brancazio, himself a cancer survivor, previously served as Board Treasurer.
Secretary
Suzanne Finnegan
Director & Chief Credit Officer
Build America Mutual
Assurance Company
Cary, NC
Treasurer
Trent Demulling
Chief Financial Officer (CFO)
Kiewit Infrastructure Company
Omaha, NE
Members
Hank Adams
Chair, Nominating Committee
Executive Vice President & Division Manager
Kiewit Infrastructure Company
Woodcliff Lake, NJ
Samuel C. Blackman, MD, PhD
Strategy Oversight Committee
Co-Founder & Chief Medical Officer
Day One Biopharmaceuticals
Seattle, WA
Cason Carter
Strategy Oversight Committee
Director, Head of Public Affairs
Citadel, LLC
Washington, DC
Brenda Weigel, MD
Chair, Scientific Advisory
Council
Director, Division of Pediatric Hematology/Oncology
University of Minnesota
Minneapolis, MN
Stacey Adam, PhD
Chair, Strategy Oversight Committee
Director of Cancer Research Partnerships at FNIH
Washington, DC
Annie Gould
Nominating Committee
Childhood Cancer Advocate
Barboursville, VA
David Kupiec
Chair, Marketing Committee
CEO/Founder
KPI Media Partners
New York, NY
David Whan
VP, People & Culture
Federal Reserve Bank of
St. Louis
Stuart E. Siegel, MD
Chair Emeritus
Retired Director, Center for Global Health
Children's Hospital Los Angeles
Pacific Palisades, CA
Jeffrey Skolnik
Chair, Industry Advisory Council
Senior Vice President, Clinical Development
Inovio
Plymouth Meeting, PA
Shari Collier
Audit Chair
Division CFO
St. David's HealthCare HCA - Central & West Texas Division
Austin, TX
Michael (Mike) R. Miller, Esquire
Emeritus
Senior Council
Fisher & Phillips, LLP
Tampa, FL
Tina Swallow
Development Committee
Sales Director for the Department of Defense and Intelligence Community
Trellix
Falls Church, VA
Ma Cherry Trivedi
Audit Committee
CEO/Founder
Ayuroma Advisory International
Singapore
Kathy Wanner
Strategy Oversight Committee
Operating Partner
Abundant Venture Partners
Chicago, IL
Paula and Mike Carter
Co-Founders, Scott Carter Foundation
Tulsa, OK
STRATEGY OVERSIGHT COMMITTEE
The Strategy Oversight Committee fosters a cooperative, interactive strategic planning process between the Board and management.
Chair
Stacey Adam, PhD
Associate Vice President, Research Partnerships
Foundation for the National Institutes of Health
Members
Cason Carter
Director, Head of Public Affairs
Citadel, LLC
Samuel C. Blackman, MD, PhD,
Co-founder & Chief Medical Officer
Day One Biopharmaceuticals
Kathy Wanner
Operating Partner
Abundant Venture Partners
Syril Petit
Executive Director
Health and Environmental Sciences Institute (HESI)
Chris Lee
Managing Director, Strategy & Corporate Development
Palladium
Gordon Cohen
Global Clinical Head
Lou Stancato, PhD
VP of Enabling Technologies and Global Leader of the Pediatric Rare Disease Platform
Indiana Biosciences Research Institute